Company intelligence / Profile preview

Gemer

New Taipei City, Taiwan

Ownership: Private
Development stage: Other

Overview

GiMer Medical is a medical technology company specializing in the development of advanced neuromodulation systems for the treatment of chronic pain. The company's flagship product is the G-SCS (GiMer Spinal Cord Stimulation) system, which utilizes high-frequency stimulation to provide relief for patients suffering from failed back surgery syndrome and complex regional pain syndrome. In addition to its proprietary medical device pipeline, GiMer Medical operates a Contract Development and Manufacturing Organization (CDMO) business unit that provides outsourced pharmaceutical and device development services. The company was acquired in late 2024, reflecting its significant role in the evolving landscape of pain management and medical device manufacturing.

Therapeutic areas: Neurology
Modalities: DeviceNeuromodulation
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Gemer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gemer.

Explore the full profile